James Huang

James (Zuie-Chin) Huang is the Executive Chairman of Chime Biologics, he also is the Founding Managing Partner of Panacea Healthcare Venture Capital (RMB 870m Fund & USD180.5m Fund). He has devoted his passion, diligence, intelligence, and loyalty to the life science and investment industry for over 30 years. He is a successful entrepreneur investor and an opinion leader in the Venture Capital healthcare sector in China. Panacea Venture is focusing on investments in innovative and transformative early and growth-stage healthcare and life sciences companies worldwide. Since its inception in 2018, Panacea has had three portfolios listed and five more submitted IPO applications. Panacea is currently raising its USD Fund II with a target fund size of USD 250 million.